These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 37989807)
1. Exploring the link between hedonic overeating and prefrontal cortex dysfunction in the Ts65Dn trisomic mouse model. Fructuoso M; Fernández-Blanco Á; Gallego-Román A; Sierra C; de Lagrán MM; Lorenzon N; De Toma I; Langohr K; Martín-García E; Maldonado R; Dairou J; Janel N; Dierssen M Cell Mol Life Sci; 2023 Nov; 80(12):370. PubMed ID: 37989807 [TBL] [Abstract][Full Text] [Related]
2. Skeletal Deficits in Male and Female down Syndrome Model Mice Arise Independent of Normalized Dyrk1a Expression in Osteoblasts. Thomas JR; Sloan K; Cave K; Wallace JM; Roper RJ Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828335 [TBL] [Abstract][Full Text] [Related]
3. Sexually dimorphic DYRK1A overexpression on postnatal day 15 in the Ts65Dn mouse model of Down syndrome: Effects of pharmacological targeting on behavioral phenotypes. Hawley LE; Prochaska F; Stringer M; Goodlett CR; Roper RJ Pharmacol Biochem Behav; 2022 Jun; 217():173404. PubMed ID: 35576991 [TBL] [Abstract][Full Text] [Related]
4. The pattern of congenital heart defects arising from reduced Tbx5 expression is altered in a Down syndrome mouse model. Polk RC; Gergics P; Steimle JD; Li H; Moskowitz IP; Camper SA; Reeves RH BMC Dev Biol; 2015 Jul; 15():30. PubMed ID: 26208718 [TBL] [Abstract][Full Text] [Related]
5. Behavioral assessment of the Ts65Dn mouse, a model for Down syndrome: altered behavior in the elevated plus maze and open field. Coussons-Read ME; Crnic LS Behav Genet; 1996 Jan; 26(1):7-13. PubMed ID: 8852727 [TBL] [Abstract][Full Text] [Related]
6. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome. Kirsammer G; Jilani S; Liu H; Davis E; Gurbuxani S; Le Beau MM; Crispino JD Blood; 2008 Jan; 111(2):767-75. PubMed ID: 17901249 [TBL] [Abstract][Full Text] [Related]
7. Increased male reproductive success in Ts65Dn "Down syndrome" mice. Moore CS; Hawkins C; Franca A; Lawler A; Devenney B; Das I; Reeves RH Mamm Genome; 2010 Dec; 21(11-12):543-9. PubMed ID: 21110029 [TBL] [Abstract][Full Text] [Related]
9. Perinatal loss of Ts65Dn Down syndrome mice. Roper RJ; St John HK; Philip J; Lawler A; Reeves RH Genetics; 2006 Jan; 172(1):437-43. PubMed ID: 16172497 [TBL] [Abstract][Full Text] [Related]
10. Dysregulated systemic metabolism in a Down syndrome mouse model. Sarver DC; Xu C; Velez LM; Aja S; Jaffe AE; Seldin MM; Reeves RH; Wong GW Mol Metab; 2023 Feb; 68():101666. PubMed ID: 36587842 [TBL] [Abstract][Full Text] [Related]
11. Non-trisomic homeobox gene expression during craniofacial development in the Ts65Dn mouse model of Down syndrome. Billingsley CN; Allen JR; Baumann DD; Deitz SL; Blazek JD; Newbauer A; Darrah A; Long BC; Young B; Clement M; Doerge RW; Roper RJ Am J Med Genet A; 2013 Aug; 161A(8):1866-74. PubMed ID: 23843306 [TBL] [Abstract][Full Text] [Related]
12. Penetrance of Congenital Heart Disease in a Mouse Model of Down Syndrome Depends on a Trisomic Potentiator of a Disomic Modifier. Li H; Edie S; Klinedinst D; Jeong JS; Blackshaw S; Maslen CL; Reeves RH Genetics; 2016 Jun; 203(2):763-70. PubMed ID: 27029737 [TBL] [Abstract][Full Text] [Related]
13. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome. Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891 [TBL] [Abstract][Full Text] [Related]
14. Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome. Blazek JD; Billingsley CN; Newbauer A; Roper RJ Dev Dyn; 2010 Jun; 239(6):1645-53. PubMed ID: 20503361 [TBL] [Abstract][Full Text] [Related]
15. Novel insights from fetal and placental phenotyping in 3 mouse models of Down syndrome. Adams AD; Hoffmann V; Koehly L; Guedj F; Bianchi DW Am J Obstet Gynecol; 2021 Sep; 225(3):296.e1-296.e13. PubMed ID: 33766516 [TBL] [Abstract][Full Text] [Related]
16. The Impact of Mmu17 Non-Hsa21 Orthologous Genes in the Ts65Dn Mouse Model of Down Syndrome: The Gold Standard Refuted. Guedj F; Kane E; Bishop LA; Pennings JLA; Herault Y; Bianchi DW Biol Psychiatry; 2023 Jul; 94(1):84-97. PubMed ID: 37074246 [TBL] [Abstract][Full Text] [Related]
17. Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes. Keck-Wherley J; Grover D; Bhattacharyya S; Xu X; Holman D; Lombardini ED; Verma R; Biswas R; Galdzicki Z Dev Neurosci; 2011; 33(5):451-67. PubMed ID: 22042248 [TBL] [Abstract][Full Text] [Related]
18. Developmental instability of the cerebellum and its relevance to Down syndrome. Shapiro BL J Neural Transm Suppl; 2001; (61):11-34. PubMed ID: 11771737 [TBL] [Abstract][Full Text] [Related]
19. Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome. Duchon A; Raveau M; Chevalier C; Nalesso V; Sharp AJ; Herault Y Mamm Genome; 2011 Dec; 22(11-12):674-84. PubMed ID: 21953411 [TBL] [Abstract][Full Text] [Related]
20. Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice. Kurt MA; Davies DC; Kidd M; Dierssen M; Flórez J Brain Res; 2000 Mar; 858(1):191-7. PubMed ID: 10700614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]